与COVID-19相关的单侧隔膜:一个病例报告
Fahimeh Hassanali1, Kazem Ahmadikia2, Maryam Sadat Mirenayat3
1Rajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
Tanaffos
|August 16, 2023
概括
这项研究报告了COVID-19肺炎患者罕见的隔膜病例. 这种情况是通过胸部X射线诊断出来的,被归因于病毒感染,突出了潜在的神经复发症.
科学领域:
- 神经学 神经学
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
背景情况:
- 隔膜麻可能是异常性或与各种疾病有关,包括病毒和细菌感染.
- 与病毒感染相关的神经麻并不常见,但在病例报告中得到了记录.
- 神经病变影响中枢和外围神经系统,是COVID-19的一种已知的神经复杂症.
相关概念视频
Pneumothorax-I
252
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
252
Pneumonia III: Complications and Assessment
266
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
266
Pleural Effusion II: Symptoms and Management
211
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
211
Pneumonia II: Pathophysiology
339
The pathophysiology of pneumonia involves the following steps:
339
Pneumothorax-II
197
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
197
Acute Respiratory Failure-II
272
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
272


